Skip to main content
. 2023 Mar 2;31(1):13–27. doi: 10.12793/tcp.2023.31.e1

Table 3. Changes in liver function parameters between groups.

Parameters Treatment group Placebo group
Baseline Day 90 Baseline Day 90
Bilirubin total 0.97 ± 0.33 0.88 ± 0.17 1.05 ± 0.41 0.92 ± 0.18
Bilirubin direct 0.34 ± 0.25 0.28 ± 0.10 0.37 ± 0.23 0.28 ± 0.11
Bilirubin indirect 0.63 ± 0.19 0.60 ± 0.12 0.68 ± 0.25 0.65 ± 0.12
SGOT 40.97 ± 23.47 33.68 ± 12.15 41.52 ± 28.00 32.03 ± 8.60
SGPT 33.87 ± 20.59 32.52 ± 17.82 34.49 ± 23.57 32.66 ± 12.18
Alkaline phosphatase 81.81 ± 22.93 84.42 ± 25.64 77.83 ± 17.72 84.59 ± 21.57
Total proteins 7.53 ± 3.11 7.11 ± 0.54 7.29 ± 0.80 7.09 ± 0.51
Serum albumin (A) 4.24 ± 0.44 4.06 ± 0.41 4.13 ± 0.39 4.03 ± 0.41
Serum globulin (G) 3.36 ± 1.67 3.04 ± 0.26 3.16 ± 0.51 3.08 ± 0.26
Serum A/G ratio 1.35 ± 0.61 1.31 ± 0.17 1.31 ± 0.18 1.28 ± 0.15

Data analyzed by Student’s t-test. Not significant at p < 0.05.